SAN DIEGO, Oct. 26 – Sun Microsystems and Viaken Systems have signed a preliminary agreement to develop and market a new suite of Viaken products, GenomeWeb has learned on Friday.
The potential deal, which is open-ended and non-exclusive, is anticipated to close in the current quarter, a Viaken spokesman said at the 13th annual Genome Sequencing and Analysis Conference, held here through Sunday.
The collaboration calls for Sun, of Cary, NC, to help Viaken develop and sell a new line of informatics products, called Paragon, atop Sun’s E series hardware, said Michael Provance, Viaken’s vice president of discovery solutions. The computer giant will also build a marketing foundation for Viaken, a Sun spokeswoman said.
The company plans to sell the suite in the United States, Europe, and Japan. It has not yet been determined which company will be responsible for the different regions, although Viaken, which is based in Gaithersburg, Md., with offices in the UK, will be the primary distributor.
Provance said that the company hopes to launch the first product in the suite, a genomic-discovery platform, in the first quarter of 2002. Other product installments, which will be rolled out through 2003, will include tools for data visualization, data mining, and project management.
Financial details of the partnership were not disclosed.
“Sun has got the architecture we need to get this done,” Provance said at his booth four aisles from Sun’s. “This is the beginning of a much larger relationship.”
He added that Viaken has several other deals lined up for closure in either the current or next quarter.
In July, Viaken partnered with e-science platform provider InforSense to market and distribute its large-scale genomic analysis and drug-discovery platform.
As GenomeWeb reported, the platform, called the Kensington Discovery Edition, was developed by Copenhagen-based InforSense as networked-based software for data mining and analysis.
Terms of that agreement were not disclosed.